MMRGlobal Receives Notice of Allowance for Sixth Patent to Include Retail Pharmacies, Hospitals and Providers
December 03 2012 - 8:35AM
Marketwired
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that it has
received a Notice of Allowance, U.S. Serial No. 13/352,068, from
the United States Patent and Trademark Office which further expands
the Company's "Method and System for Providing Online Medical
Records." In short, the most recent allowed application expands
MMR's patent portfolio with additional claims directed toward a
Web-based service to access and collect health records from
different types of service providers, including, but not limited
to, retail pharmacies as well as hospitals, providers and other
healthcare professionals providing services over the Internet. The
health records, including prescriptions, may be collected from
service providers using various types of messaging including email,
facsimile, uploads, and voice. Moreover, there are additional
claims in the newly allowed patent application related to
collecting insurance information, calendaring, and other features,
which are already provided by MMR's products and services.
According to John Goodhue at McKee, Voorhees & Sease
(www.ipmvs.com), patent counsel to the Company since filing of its
first patents in 2005, "This is a significant addition to
MMRGlobal's health IT patent portfolio because it potentially
affects retail establishments that maintain Personal Health Records
for customers and fill prescriptions online. The resulting patent
will grant further protection to the Company by allowing it to
assert legal claims against service providers offering Web-based
portals for consumer access to personal health information when
those service providers do so in an infringing manner, unless the
services are provided by or licensed from the Company."
The Company has sent hundreds of letters to hospitals,
healthcare professionals and vendors noticing its health IT patents
and other opportunities to utilize MMR's MyMedicalRecords.com and
MMRPro service offerings, or to license the Company's patented
technology. As MMR prepares for the upcoming Consumer Electronics
Show in Las Vegas in January, it will expand its efforts to notice
major retail pharmacies who have the opportunity to offer the
Company's Prepaid Personal Health Record cards or license the
Company's IP as part of their online pharmacy programs. Trade
associations, particularly hospitals, have responded to the Company
with questions which MMR has answered and in several cases have
resulted in the beginning of negotiations for licenses of the
Company's intellectual property with vendors of EMR services,
hospitals and associations.
The Company's patents come in advance of the Stage 2 Meaningful
Use requirement that patients have online access to their protected
health information through a Personal Health Record or other form
of patient portal by 2014. The Company believes that this most
recent Notice of Allowance when combined with the Company's
existing patents will make it increasingly difficult for eligible
healthcare professionals to fully qualify for incentives under
HITECH Act without a license because one of the requirements is to
provide patients access to their personal health information
through a Web-based portal.
About MMRGlobal, Inc. MMRGlobal, Inc.,
through its wholly-owned operating subsidiary, MyMedicalRecords,
Inc., provides secure and easy-to-use online Personal Health
Records ("PHRs") and electronic safe deposit box storage solutions,
serving consumers, healthcare professionals, employers, insurance
companies, financial institutions, and professional organizations
and affinity groups. The MyMedicalRecords PHR enables individuals
and families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. The Company's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real
time through an integrated patient portal. MMR is an Independent
Software Vendor Partner with Kodak to deliver an integrated turnkey
EMR solution for healthcare professionals. Through its merger with
Favrille, Inc. in January 2009, the Company acquired intellectual
property biotech assets that include anti-CD20 antibodies and data
and samples from its FavId™/Specifid™ vaccine clinical trials for
the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about
MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of the Company's products and services at
www.mmrtheater.com.
Forward-Looking Statements All statements
in this press release that are not strictly historical in nature,
including, without limitation, intellectual property licenses,
potential intellectual property enforcement actions, infringement
claims or litigation, and future performance, management's
expectations, beliefs, intentions, estimates or projections,
constitute "forward-looking statements." Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the Company's actual results to be
materially different from historical results or from any results
expressed or implied by such forward-looking statements. Some can
be identified by the use of words (and their derivations) such as
"need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes of
intellectual property enforcement actions, infringement claims,
litigation or licensing transactions, results of operations and the
timing of selected events may differ materially from the results
predicted, and any reported results should not be considered as an
indication of future performance. Such statements are necessarily
based on assumptions and estimates and are subject to various risks
and uncertainties, including those relating to the possible
invalidity of the underlying assumptions and estimates and possible
changes or developments in economic, business, industry, market,
legal and regulatory circumstances and conditions and actions taken
or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, monetize and
protect our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection
with licensing our intellectual property; our ability to establish
and maintain strategic relationships; changes in our relationships
with our licensees; the risk the Company's products are not adopted
or viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
competitive product offerings and promotions; changes in government
laws and regulations including the 2009 HITECH Act and changes in
Meaningful Use and the 2010 Affordable Care Act; future changes in
tax legislation and initiatives in the healthcare industry;
undetected errors in our products; the possibility of interruption
at our data centers; risks related to third party vendors; risks
related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties;
risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing
business internationally across borders and territories; and
additional risks discussed in the Company's filings with the
Securities and Exchange Commission. The Company is providing this
information as of the date of this release and, except as required
by applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise.
Add to Digg Bookmark with del.icio.us Add to Newsvine
CONTACT: Michael Selsman Public Communications Co. (310)
922-7033 ms@publiccommunications.biz